H&R GMBH & CO KGAA (2HRA.DE) Stock Fundamental Analysis
FRA:2HRA - Deutsche Boerse Ag - DE000A2E4T77 - Common Stock - Currency: EUR
Overall 2HRA gets a fundamental rating of 4 out of 10. We evaluated 2HRA against 61 industry peers in the Chemicals industry. 2HRA has an average financial health and profitability rating. 2HRA scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year 2HRA was profitable.
In the past year 2HRA had a positive cash flow from operations.
Of the past 5 years 2HRA 4 years were profitable.
2HRA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
2HRA has a Return On Assets (1.05%) which is comparable to the rest of the industry.
The Return On Equity of 2HRA (2.49%) is comparable to the rest of the industry.
2HRA has a Return On Invested Capital (2.65%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for 2HRA is below the industry average of 6.29%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.05% | ||
| ROE | 2.49% | ||
| ROIC | 2.65% |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
1.3 Margins
With a Profit Margin value of 0.79%, 2HRA perfoms like the industry average, outperforming 50.82% of the companies in the same industry.
In the last couple of years the Profit Margin of 2HRA has declined.
The Operating Margin of 2HRA (2.41%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of 2HRA has grown nicely.
2HRA has a Gross Margin (23.61%) which is in line with its industry peers.
In the last couple of years the Gross Margin of 2HRA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.41% | ||
| PM (TTM) | 0.79% | ||
| GM | 23.61% |
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 2HRA is destroying value.
Compared to 1 year ago, 2HRA has about the same amount of shares outstanding.
Compared to 5 years ago, 2HRA has about the same amount of shares outstanding.
2HRA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.15 indicates that 2HRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.15, 2HRA is in line with its industry, outperforming 55.74% of the companies in the same industry.
The Debt to FCF ratio of 2HRA is 9.97, which is on the high side as it means it would take 2HRA, 9.97 years of fcf income to pay off all of its debts.
2HRA has a Debt to FCF ratio of 9.97. This is comparable to the rest of the industry: 2HRA outperforms 59.02% of its industry peers.
2HRA has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
2HRA's Debt to Equity ratio of 0.15 is amongst the best of the industry. 2HRA outperforms 85.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 9.97 | ||
| Altman-Z | 2.15 |
ROIC/WACC0.48
WACC5.55%
2.3 Liquidity
2HRA has a Current Ratio of 1.53. This is a normal value and indicates that 2HRA is financially healthy and should not expect problems in meeting its short term obligations.
2HRA has a Current ratio (1.53) which is in line with its industry peers.
2HRA has a Quick Ratio of 1.53. This is a bad value and indicates that 2HRA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.80, 2HRA is doing worse than 75.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.8 |
3. Growth
3.1 Past
2HRA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.56%.
The earnings per share for 2HRA have been decreasing by -40.40% on average. This is quite bad
2HRA shows a decrease in Revenue. In the last year, the revenue decreased by -1.04%.
2HRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.47% yearly.
EPS 1Y (TTM)1.56%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%636.62%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%2.91%
3.2 Future
Based on estimates for the next years, 2HRA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.75% on average per year.
Based on estimates for the next years, 2HRA will show a small growth in Revenue. The Revenue will grow by 1.35% on average per year.
EPS Next Y34.75%
EPS Next 2Y40.41%
EPS Next 3Y27.75%
EPS Next 5YN/A
Revenue Next Year1.1%
Revenue Next 2Y1.85%
Revenue Next 3Y1.35%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.14, 2HRA is valued correctly.
78.69% of the companies in the same industry are more expensive than 2HRA, based on the Price/Earnings ratio.
2HRA is valuated rather cheaply when we compare the Price/Earnings ratio to 24.12, which is the current average of the S&P500 Index.
2HRA is valuated correctly with a Price/Forward Earnings ratio of 12.26.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 2HRA indicates a somewhat cheap valuation: 2HRA is cheaper than 77.05% of the companies listed in the same industry.
2HRA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.14 | ||
| Fwd PE | 12.26 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 2HRA indicates a rather cheap valuation: 2HRA is cheaper than 98.36% of the companies listed in the same industry.
83.61% of the companies in the same industry are more expensive than 2HRA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.68 | ||
| EV/EBITDA | 2.21 |
4.3 Compensation for Growth
2HRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
2HRA's earnings are expected to grow with 27.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y40.41%
EPS Next 3Y27.75%
5. Dividend
5.1 Amount
2HRA has a Yearly Dividend Yield of 2.46%.
Compared to an average industry Dividend Yield of 3.10, 2HRA has a dividend in line with its industry peers.
2HRA's Dividend Yield is comparable with the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.46% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
35.04% of the earnings are spent on dividend by 2HRA. This is a low number and sustainable payout ratio.
DP35.04%
EPS Next 2Y40.41%
EPS Next 3Y27.75%
FRA:2HRA (5/8/2025, 7:00:00 PM)
3.96
-0.04 (-1%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners1.39%
Inst Owner ChangeN/A
Ins Owners6.06%
Ins Owner ChangeN/A
Market Cap147.39M
Analysts40
Price Target4.01 (1.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.46% |
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP35.04%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-37.57%
PT rev (3m)-37.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.86%
EPS NY rev (3m)-13.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)-0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.14 | ||
| Fwd PE | 12.26 | ||
| P/S | 0.11 | ||
| P/FCF | 9.68 | ||
| P/OCF | 2.1 | ||
| P/B | 0.35 | ||
| P/tB | 0.37 | ||
| EV/EBITDA | 2.21 |
EPS(TTM)0.28
EY7.07%
EPS(NY)0.32
Fwd EY8.16%
FCF(TTM)0.41
FCFY10.33%
OCF(TTM)1.89
OCFY47.66%
SpS35.95
BVpS11.47
TBVpS10.66
PEG (NY)0.41
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.05% | ||
| ROE | 2.49% | ||
| ROCE | 4.47% | ||
| ROIC | 2.65% | ||
| ROICexc | 2.96% | ||
| ROICexgc | 3.11% | ||
| OM | 2.41% | ||
| PM (TTM) | 0.79% | ||
| GM | 23.61% | ||
| FCFM | 1.14% |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
ROICexc(3y)4.64%
ROICexc(5y)4.53%
ROICexgc(3y)4.9%
ROICexgc(5y)4.79%
ROCE(3y)7.11%
ROCE(5y)6.95%
ROICexcg growth 3Y-25.59%
ROICexcg growth 5Y22.95%
ROICexc growth 3Y-25.37%
ROICexc growth 5Y23.82%
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
F-Score5
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 9.97 | ||
| Debt/EBITDA | 0.67 | ||
| Cap/Depr | 87.57% | ||
| Cap/Sales | 4.11% | ||
| Interest Coverage | 3.5 | ||
| Cash Conversion | 73.93% | ||
| Profit Quality | 143.37% | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.8 | ||
| Altman-Z | 2.15 |
F-Score5
WACC5.55%
ROIC/WACC0.48
Cap/Depr(3y)102.18%
Cap/Depr(5y)93.34%
Cap/Sales(3y)4.27%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.56%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%636.62%
EPS Next Y34.75%
EPS Next 2Y40.41%
EPS Next 3Y27.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%2.91%
Revenue Next Year1.1%
Revenue Next 2Y1.85%
Revenue Next 3Y1.35%
Revenue Next 5YN/A
EBIT growth 1Y4.91%
EBIT growth 3Y-23.19%
EBIT growth 5Y31.47%
EBIT Next Year225.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.2%
FCF growth 3YN/A
FCF growth 5Y-5.95%
OCF growth 1Y-41.01%
OCF growth 3Y23.36%
OCF growth 5Y-6.03%